Wei Hui Zheng

Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province

Zhejiang Cancer Hospital

BIOGRAPHY

Wei Hui Zheng has not added Biography.

If you are Wei Hui Zheng and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.

Breast cancer research and treatment Jun, 2013 | Pubmed ID: 23670132

p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up.

Medical oncology (Northwood, London, England) Nov, 2014 | Pubmed ID: 25270283

Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas.

Medical oncology (Northwood, London, England) Jan, 2015 | Pubmed ID: 25432700

The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.

PloS one , 2015 | Pubmed ID: 26177369

An extrathyroid CASTLE tumor in the left neck.

Oral oncology Oct, 2020 | Pubmed ID: 32245700

Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.

Endocrine, metabolic & immune disorders drug targets , 2021 | Pubmed ID: 32660411

Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.

BMC cancer Apr, 2021 | Pubmed ID: 33827484

Genomic variation associated with carcinoma showing thymus-like elements (CASTLE) in thyroid gland.

Laryngoscope investigative otolaryngology Jun, 2022 | Pubmed ID: 35734076

A large-scale study of patients with preoperative vocal cord paralysis associated with thyroid disease and related clinicopathological features.

Ear, nose, & throat journal Jul, 2022 | Pubmed ID: 35856809

INSTITUTIONS

Zhejiang Cancer Hospital

Department of Thyroid Surgery of Zhejiang Cancer Hospital

JOVE ARTICLES

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay

Kelvin Kam Yew Kuan^*,1,

Ke Zhang^*,1,2,

Koon Hwee Ang¹,

Min Thura¹,

Wei Hui Zheng^3,4

¹Institute of Molecular and Cell Biology (IMCB), A*STAR 61 Biopolis Drive,

²Department of Radiation Oncology, Affiliated Hangzhou Cancer Hospital,

³Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital,

⁴, Department of Thyroid Surgery of Zhejiang Cancer Hospital

Immunology and Infection

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog

Wei Hui Zheng

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province

Zhejiang Cancer Hospital

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay

Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province